Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft.
Molnar
I
I
Keung
Y K
YK
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008181:Lupus Nephritis / Q000601:surgery; D016393:Lymphoma, B-Cell / Q000209:etiology / Q000532:radiotherapy / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology / Q000532:radiotherapy / Q000628:therapy; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D012086:Reoperation; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab